Idexx Laboratories (IDXX) insider trading

By person

18 insiders · 21 transactions

51.1×

Jonathan J. Mazelsky holds 51.1 times base salary in stock. $58.80M of shares against $1.15M in salary for 2025.

Salary from the company's own proxy. The shares are what Jonathan J. Mazelsky last reported holding, valued at $701.69, the price Common Stock was last bought or sold at on the open market here, on 4 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Jonathan Jay Mazelsky

Executive Chair of the Board

—

$17.68M (13) scheduled

−$17.68M

83,803

0.1064%

$58.80M

+2.4%

Sharon E. Underberg

EVP, GC & Corporate Secretary

—

$6.13M (3) scheduled

−$6.13M

7,169

0.0091%

$5.03M

+25.3%

Michael Lane

Executive Vice President

—

$2.74M (3)

−$2.74M

4,668

0.0059%

$3.28M

−34.8%

Daniel M Junius

Director

—

$844.89K (2)

−$844.89K

2,361

0.0030%

$1.66M

−22.4%

Brian P McKeon

EVP, CFO and Treasurer

—

31,550

0.0400%

$22.14M

+1.9%

Nimrata Hunt

Executive Vice President

—

18,141

0.0230%

$12.73M

+54.1%

Michael G Erickson

Executive Vice President

—

15,092

0.0192%

$10.59M

+54.2%

George Fennell

Executive Vice President

—

10,433

0.0132%

$7.32M

+50.8%

Lawrence D Kingsley

Director

—

9,568

0.0121%

$6.71M

+7.7%

Andrew Emerson

EVP, CFO and Treasurer

—

4,421

0.0056%

$3.10M

+79.6%

Michael Schreck

Executive Vice President

—

3,089

0.0039%

$2.17M

+212.7%

Michael Perkins Johnson

Executive Vice President

—

2,795

0.0035%

$1.96M

+899.2%

Stuart Essig

Director

—

2,236

0.0028%

$1.57M

+13.3%

Martin Alexander Smith

Executive Vice President

—

2,157

0.0027%

$1.51M

+268.9%

Sophie Vandebroek V.

Director

—

905

0.0011%

$635.02K

−38.6%

M Anne Szostak

Director

—

778

0.0010%

$545.91K

−82.8%

Joseph L Hooley

Director

—

373

0.0005%

$261.73K

—

Karen Peacock

Director

—

102

0.0001%

$71.57K

+10,100%

Idexx Laboratories

What the insiders did Net selling

By person